e-ISSN: 2717-7149
  • Home
  • About The Journal
  • Editorial Board
  • Instructions for Authors
  • Contact
Current Issue
Ahead Of Print
Archive
Search
Most Popular
Download Articles Read Articles
Retina Arter Tıkanıklıkları ve Tedavisi...
Santral Retinal Ven Tıkanıklığı Güncel Tedavisi...
Central Retinal Artery Occlusion As the Cause of Unilateral Concentric Narrowing of Visual Field and Presence of Cilioretinal Artery...
Bilateral Optic Disc Drusen
Vascular Endothelial Growth Factor and Anti VEGF Agents...
Central Retinal Artery Occlusion As the Cause of Unilateral Concentric Narrowing of Visual Field and Presence of Cilioretinal Artery...
Retina Arter Tıkanıklıkları ve Tedavisi...
Morning Glory Syndrome Associated with Retinochoroidal Coloboma...
Santral Retinal Ven Tıkanıklığı Güncel Tedavisi...
Bilateral Optic Disc Drusen
PureSee Kesintisiz Yüksek Kalitede Görüş
Retina-Vitreous 2014 , Vol 22 , Num 0
Turkish Abstract Abstract Article PDF Similar Articles Mail to Author
Anti-VEGF Treatments in Retİnal Diseases
SİBEL KADAYIFÇILAR
Hacettepe University Faculty of Medicine, Department of Ophthalmology, Ankara/TURKEY Vascular endothelial growth factor (VEGF) is the most important factor in ocular angiogenesis. Recently developed antiVEGF agents have revolutionized the treatment of many retinal diseases.These agents control both neovascularization and increased permeability, hence in many diseases that could end in vision loss, the visual acuity can be preserved or increased. Keywords : Aflibercept, bevacizumab, macular edema, neovascularization, ranibizumab, VEGF
PureSee Kesintisiz Yüksek Kalitede Görüş
Home
About The Journal
Editorial Board
Instructions for Authors
Contact